Cited by 58Gut microbiota and healthBerberine and alkaloids researchProbiotics and Fermented Foods

Comprehensive Evaluation of SCFA Production in the Intestinal Bacteria Regulated by Berberine Using Gas-Chromatography Combined with Polymerase Chain Reaction

Wang, Lu-Lu, Guo, Hui-Hui, Huang, Shuai, Feng, Chen-Lin, Han, Yan-Xing, Jiang, Jian-Dong·2017·Journal of Chromatography B

Abstract

Short-chain fatty acids (SCFAs) of intestine microbial have caught accumulating attention for their beneficial effects on human health. Botanic compounds with low bioavailability such as berberine (BBR) and resveratrol might interact with intestinal microbial ecosystem and promote gut bacteria to produce SCFA, which contribute to their biological effects. In the present study, a comprehensive assay system was built to detect SCFAs production in intestinal bacteria, in which stringent anaerobic culture was applied for in vitro bacterial fermentation, followed by direct-injection GC detection (chemical detection) in combination with real time polymerase chain reaction (RT-PCR, biological detection). BBR was used as positive reference. The direct injection GC method was calibrated and successfully applied to analyze the concentration of SCFAs in gut microbiota and BBR was proved to be effective in the dose- and time-dependent up-regulation of SCFAs production. As compared to the saline group, the concentration of acetic acid, propionate acid and butyric acid (the main SCFAs in gut microbiota) were increased by 17.7%, 11.1% and 30.5%, respectively, after incubating intestinal bacteria with 20μg/mL BBR for 24h. The increase reached to 34.9%, 22.4% and 51.6%, respectively when the BBR was 50μg/mL. Additionally, consensus-degenerate hybrid oligonucleotide primers (CODEHOPs) were designed for the detection of acetate kinase (ACK), Methylmalonyl-CoA decarboxylase (MMD) and butyryl-CoA: acetate-CoA transferase (BUT), as they are the key enzymes in the synthetic pathway for acetic acid, propionate acid and butyric acid, respectively. After 24hr's incubation, BBR was shown to promote the gene expression of ACK, MMD and BUT significantly (86.5%, 27.2% and 60.4%, respectively, with 20μg/mL BBR; 130.2%, 84.2% and 98.4%, respectively, with 50μg/mL BBR), showing a solid biological support for the chemical detection. This comprehensive assay system might be useful in identifying SCFAs promoting agents with information on their mechanism.

Integrity signals

Registry

Crossref · 10.1016/j.jchromb.2017.05.004

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • It is likely that resveratrol and epicatechin may improve muscle atrophy by regulating the gut microbiota and their metabolites.

    “Considering the reported anti-muscle atrophy effect of some nutraceuticals, such as resveratrol and epicatechin, and the fact that they could modulate the gut microbiome composition and increase circulating levels of short-chain fatty acids [167,168], it is likely that they may improve muscle atrophy by regulating the gut microbiota and their metabolites; nevertheless, future confirmatory studies”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Wang, L.-L., Guo, H.-H., Huang, S., Feng, C.-L., Han, Y.-X., & Jiang, J.-D.
Affiliations
Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
Corresponding author
Jiang, Jian-Dong
Venue
Journal of Chromatography B
Publisher
Elsevier BV
Published
2017-07
Volume
1057
Pages
70-80
ISSN
1570-0232 (ISSN-L)
OpenAlex
W2613604801
Cited by
58
References
66
Citations by year
2026: 4 · 2025: 7 · 2024: 3 · 2023: 6 · 2022: 8 · 2021: 7 · 2020: 8 · 2019: 11 · 2018: 4
FWCI
2.57
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Chromatography B (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Health and Family Planning Commission
  • Beijing Key Laboratory of Non-Clinical Drug Metabolism and PK/PD study
  • CAMS Major Collaborative Innovation Project
  • Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Pharmacology › Berberine and alkaloids research
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
Keywords
short-chain fatty acids, berberine, gut microbiota, acetate kinase, butyrate, acetic acid, gene expression, resveratrol
MeSH terms
Gastrointestinal Microbiome, Animals, Bacteria, Berberine, Chromatography, Gas, Fatty Acids, Volatile, Humans, Intestines, Rats, Sprague-Dawley, Rats, Real-Time Polymerase Chain Reaction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review